Survival and response results from XELOX-1/NO16966: A randomized phase III trial of XELOX vs. FOLFOX4 as first-line treatment for patients with metastatic colorectal cancer (MCRC) Meeting Abstract


Authors: Cassidy, J.; Clarke, S.; Díaz-Rubio, E.; Scheithauer, W.; Figer, A.; Wong, R.; Koski, S.; Lichinitser, M.; Yang, T.; Saltz, L.
Abstract Title: Survival and response results from XELOX-1/NO16966: A randomized phase III trial of XELOX vs. FOLFOX4 as first-line treatment for patients with metastatic colorectal cancer (MCRC)
Meeting Title: 9th World Congress on Gastrointestinal Cancer
Keywords: fluorouracil; oxaliplatin; leucovorin
Journal Title: Annals of Oncology
Volume: 18
Issue: Suppl. 7
Meeting Dates: 2007 Jun 28-Jul 1
Meeting Location: Barcelona, Spain
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2007-01-01
Start Page: vii19
Language: English
ACCESSION: WOS:000249280800028
PROVIDER: wos
DOI: 10.1093/annonc/mdm211
PUBMED: 17926362
Notes: Meeting Abstract: O-0026 - 9th World Congress on Gastrointestinal Cancer - JUN 28-JUL 01, 2007 - Barcelona, SPAIN - "Source: Wos"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Leonard B Saltz
    790 Saltz